Reasons for changing treatment to oral agents in multiple sclerosis

Authors
Category Primary study
JournalEuropean Journal of Hospital Pharmacy
Year 2017
This article has no abstract
Epistemonikos ID: ca8d7c49feb8ce273ad5ba305957753faad41e23
First added on: Feb 08, 2025